## Abstract ## Objective To identify the prevalence of serologically active clinically quiescent (SACQ) patients in a cohort of 290 patients with systemic lupus erythematosus (SLE). We investigated if the presence of anti–double‐stranded DNA (anti‐dsDNA) or antinucleosome (anti‐NCS) antibodies dur
Low plasma androgens in women with active or quiescent systemic lupus erythematosus
✍ Scribed by Paul Jungers; Khalil Nahoul; Clara Pelissier; Maxime Dougados; FrançLois Tron; Jean-FrançOis Bach
- Publisher
- John Wiley and Sons
- Year
- 1982
- Tongue
- English
- Weight
- 347 KB
- Volume
- 25
- Category
- Article
- ISSN
- 0004-3591
No coin nor oath required. For personal study only.
✦ Synopsis
Because women comprise the majority of patients with systemic lupus erythematosus (SLE) (1) and androgens confer protective effects in murine lupus (2-5), it seems possible that sex-linked hormonal factors may modulate the expression of the disease. Serum testosterone levels have already been studied in men who have SLE (6,7), but data on androgen metabolism in women who have SLE are still lacking. We assessed plasma androgen levels in female SLE patients. Preliminary results in the quiescent phase of the disease showed low plasma androgen levels (8); now we have completed our tests and also studied patients during the active phase of their disease.
PATIENTS AND METHODS
Patients. Thirteen female SLE patients between 18 and 42 years of age were studied. All had regular menses, none of them had received oral contraceptive therapy, nor had any been previously treated with cyclophosphamide; liver enzymes were normal in all at the time of study.
The patients were divided into two groups (Table I), according to the disease activity defined on a clinical basis
📜 SIMILAR VOLUMES
Maternal serum inhibin A levels are increased on average in pregnancies affected by Down syndrome (DS). However, some reports have found increased serum levels in women with pre-eclamptic toxaemia as well. In the current study, maternal serum inhibin A was retrospectively measured in a series of 32
## Abstract ## Objective To determine the association between race/ethnicity and bone mineral density (BMD) in women with systemic lupus erythematosus (SLE). ## Methods Women with SLE (n = 298), including 77 African Americans and 221 whites, completed this cross‐sectional study conducted from 19